Alzheimer disease: New light on an old CLU

Nature Reviews Neurology

Volumn 6, Issue 1, 2010, Pages 11-13

  Bertram, Lars ^a   Tanzi, Rudolph E ^b  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CLATHRIN ASSEMBLY PROTEIN; CLUSTERIN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4B; NEUROTRANSMITTER; PHOSPHATIDYLINOSITOL; PRESENILIN 1; PRESENILIN 2; PROTEIN CR1; PROTEIN PICALM; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; COHORT ANALYSIS; EUROPE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY; UNITED STATES;

ALZHEIMER DISEASE; CLUSTERIN; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; MULTICENTER STUDIES AS TOPIC; RECEPTORS, COMPLEMENT 3B; RISK FACTORS;

EID: 75149114132     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.213     Document Type: Short Survey

References (10)

1. Bertram, L. & Tanzi, R. e. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 9, 768-778 (2008).
2. Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094-1099 (2009).
3. Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41, 1088-1093 (2009).
4. Bertram, L., McQueen, M., Mullin, K., Blacker, D. & Tanzi, R. The AlzGene Database. Alzheimer Research Forum [online], http://www.alzgene.org (2009).
5. Reiman, e. M. et al. GAB2 alleles modify Alzheimer's risk in APOe epsilon4 carriers. Neuron 54, 713-720 (2007).
6. Li, H. et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol. 65, 45-53 (2008).
7. Bertram, L. et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOe. Am. J. Hum. Genet. 83, 623-632 (2008).
8. Zlokovic, B. v. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and e: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci. 59, 1483-1497 (1996).
9. wyss-Coray, T. et al. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc. Natl Acad. Sci. USA 99, 10837-10842 (2002).
10. Harel, A., wu, F., Mattson, M. P., Morris, C. M. & Yao, P. J. evidence for CALM in directing vAMP2 trafficking. Traffic 9, 417-429 (2008).